Cocrystal Pharma, Inc. Long-Term Debt

Quick Answer

Cocrystal Pharma, Inc. reported Long-Term Debt of $49.94 million for fiscal year 2015.

Cocrystal Pharma, Inc. Long-Term Debt — Annual History

Fiscal Year Long-Term Debt YoY Change
2015 $49.94M -23.5%
2014 $65.26M
  • Cocrystal Pharma, Inc. showed a decrease of -23.5% in Long-Term Debt compared to the prior fiscal year.
  • Over the 2014–2015 period, Cocrystal Pharma, Inc.’s long-term debt has declined by 23.5% (from $65.26 million to $49.94 million).
  • The most recent figure is from Cocrystal Pharma, Inc.’s fiscal year 2015 report (Form 10-K), filed with the SEC on March 15, 2016.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment